Literature DB >> 26261566

The role of high mobility group box 1 (HMGB-1) in the diabetic retinopathy inflammation and apoptosis.

Yao Yu1, Lu Yang2, Jinlei Lv3, Xu Huang4, Jinglin Yi4, Chonggang Pei5, Yi Shao5.   

Abstract

Diabetic Retinopathy (DR) is one of the most common complications of the late phase diabetes, and also a common cause of blindness. High mobility group box 1 (HMGB-1) is considered to be an inflammatory mediator in the late phase that promotes inflammation and neovascularization in diabetes. Therefore, this paper discussed the role of HMGB-1 in diabetic retinopathy inflammation and neovascularization. 96 adult SD rats were randomly divided into control and diabetes group. The diabetic rat model was established by intraperitoneal injection of streptomycin (0.1 mol/L). Western blot was applied to determine HMGB-1 and its receptor RAGE and TLR2 protein expression in the serum. TUNEL was used to detect retinal apoptosis. Immunofluorescence was performed to test HMGB1 protein expression in retina. HBGM-1 and RAGE expression in diabetic rat retina was significantly higher than the control (P < 0.05), while TLR2 expression was lower (P < 0.05). TUNEL detection showed that diabetic rat retinal cells presented obviously higher apoptosis rate (P < 0.05). Immunofluorescence test revealed that HMGB1 largely expressed in the diabetic rat retinal cells (P < 0.05). HMGB1 may involve in the pathogenesis of diabetic retinopathy by binding with RAGE receptor to accelerate rat retinal cells apoptosis.

Entities:  

Keywords:  Diabetes; HMGB-1; apoptosis; retinal inflammation

Mesh:

Substances:

Year:  2015        PMID: 26261566      PMCID: PMC4525900     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

1.  t-Butyl hydroperoxide and oxidized low density lipoprotein enhance phospholipid hydrolysis in lipopolysaccharide-stimulated retinal pericytes.

Authors:  G Lupo; C D Anfuso; N Ragusa; R P Strosznajder; M Walski; M Alberghina
Journal:  Biochim Biophys Acta       Date:  2001-03-30

2.  Retinopathy in diabetes.

Authors:  Donald S Fong; Lloyd Aiello; Thomas W Gardner; George L King; George Blankenship; Jerry D Cavallerano; Fredrick L Ferris; Ronald Klein
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

3.  A new group of chromatin-associated proteins with a high content of acidic and basic amino acids.

Authors:  G H Goodwin; C Sanders; E W Johns
Journal:  Eur J Biochem       Date:  1973-09-21

Review 4.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.

Authors:  Michael T Lotze; Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2005-04       Impact factor: 53.106

5.  Amyloid beta(1-42) and its beta(25-35) fragment induce activation and membrane translocation of cytosolic phospholipase A2 in bovine retina capillary pericytes.

Authors:  Carmelina Daniela Anfuso; Giovanna Assero; Gabriella Lupo; Ambra Nicotra; Giuseppe Cannavò; Robert P Strosznajder; Piero Rapisarda; Ryszard Pluta; Mario Alberghina
Journal:  Biochim Biophys Acta       Date:  2004-11-08

Review 6.  The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis.

Authors:  Yu Chen; Wei Sun; Rongfen Gao; Yuying Su; Hisanori Umehara; Lingli Dong; Feili Gong
Journal:  Rheumatology (Oxford)       Date:  2013-04-12       Impact factor: 7.580

7.  A central role for inflammation in the pathogenesis of diabetic retinopathy.

Authors:  Antonia M Joussen; Vassiliki Poulaki; Minh Ly Le; Kan Koizumi; Christina Esser; Hanna Janicki; Ulrich Schraermeyer; Norbert Kociok; Sascha Fauser; Bernd Kirchhof; Timothy S Kern; Anthony P Adamis
Journal:  FASEB J       Date:  2004-07-01       Impact factor: 5.191

8.  Pericytes and the pathogenesis of diabetic retinopathy.

Authors:  Hans-Peter Hammes; Jihong Lin; Oliver Renner; Moshe Shani; Andrea Lundqvist; Christer Betsholtz; Michael Brownlee; Urban Deutsch
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

Review 9.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

10.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  13 in total

Review 1.  Novel understanding of high mobility group box-1 in the immunopathogenesis of incisional hernias.

Authors:  Nicholas K Larsen; Matthew J Reilly; Finosh G Thankam; Robert J Fitzgibbons; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2019-04-25       Impact factor: 4.473

2.  Alcohol-dependent pulmonary inflammation: A role for HMGB-1.

Authors:  Brianna Harris; Akeem Mcalister; Tacriasha Willoughby; Vijay Sivaraman
Journal:  Alcohol       Date:  2018-10-02       Impact factor: 2.405

3.  High Mobility Group Box 1 Protein in Osteoarthritic Knee Tissue and Chondrogenic Progenitor Cells: An Ex Vivo and In Vitro Study.

Authors:  Gunar Wagner; Christoph Lehmann; Christa Bode; Nicolai Miosge; Andrea Schubert
Journal:  Cartilage       Date:  2019-03-26       Impact factor: 4.634

4.  Quercetin protects against diabetic retinopathy in rats by inducing heme oxygenase-1 expression.

Authors:  Guang-Rui Chai; Shu Liu; Hong-Wei Yang; Xiao-Long Chen
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

Review 5.  High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications.

Authors:  Han Wu; Zheng Chen; Jun Xie; Li-Na Kang; Lian Wang; Biao Xu
Journal:  Mediators Inflamm       Date:  2016-10-25       Impact factor: 4.711

Review 6.  The Role of HMGB1 in the Pathogenesis of Type 2 Diabetes.

Authors:  Yanan Wang; Jixin Zhong; Xiangzhi Zhang; Ziwei Liu; Yuan Yang; Quan Gong; Boxu Ren
Journal:  J Diabetes Res       Date:  2016-12-22       Impact factor: 4.011

7.  Expression of High-Mobility Group Box 1 Protein (HMGB1) and Toll-Like Receptor 9 (TLR9) in Retinas of Diabetic Rats.

Authors:  Shuang Jiang; Xiaolong Chen
Journal:  Med Sci Monit       Date:  2017-06-25

8.  HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.

Authors:  Shuang Jiang; Xiaolong Chen
Journal:  Drug Des Devel Ther       Date:  2017-03-15       Impact factor: 4.162

Review 9.  The Complex Relationship between Diabetic Retinopathy and High-Mobility Group Box: A Review of Molecular Pathways and Therapeutic Strategies.

Authors:  Marcella Nebbioso; Alessandro Lambiase; Marta Armentano; Giosuè Tucciarone; Vincenza Bonfiglio; Rocco Plateroti; Ludovico Alisi
Journal:  Antioxidants (Basel)       Date:  2020-07-26

10.  Protective role and molecular mechanism of action of Nesfatin-1 against high glucose-induced inflammation, oxidative stress and apoptosis in retinal epithelial cells.

Authors:  Haiyan Sun; Huahui Zhao; Zhipeng Yan; Xiaokun Liu; Pengfei Yin; Jun Zhang
Journal:  Exp Ther Med       Date:  2021-06-03       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.